PACKETFABRIC NOW OFFERS DIRECT CONNECTIVITY TO CLOUD SERVICE PROVIDERS.
Culver City, Calif., January 22, 2018 – PacketFabric, the highly scalable, hyper-meshed, connectivity-as-a-service platform and a member of the NantWorks ecosystem of companies, announces today the availability of its cloud on-ramp product. PacketFabric now offers direct, secure and scalable network connectivity to cloud products from any point on PacketFabric’s Layer 2, meshed private network.
PacketFabric’s cloud connectivity service simplifies the process of establishing direct connectivity to cloud service providers, with options for dedicated connectivity or cost-effective, aggregated connectivity. At launch, PacketFabric offers connectivity to cloud service providers including Amazon Web Services (AWS), Microsoft Azure, Google Cloud Platform, IBM Cloud, Packet, and Markley Cloud Services. Cloud connectivity can be provisioned and managed using PacketFabric’s web portal or Application Program Interface (API). All networking services provided by PacketFabric are backed by a carrier-grade Service Level Agreement (SLA).
“We established PacketFabric in order to securely transmit big data at terabit-scale across our supercomputer network to interrogate the cancer genome in real time,” states Dr. Patrick Soon-Shiong, Chairman and CEO of NantWorks. “I am excited at the milestone of now connecting various Cloud Service Providers to enable broader access of the unique layer 2 networking capability afforded by our infrastructure.”
“We’ve seen a great demand for direct connectivity to cloud service providers, especially for high bandwidth connectivity,” comments Jezzibell Gilmore, SVP of Business Development at PacketFabric. “Cloud services have matured, and today companies have increasing bandwidth requirements, as well as a growing need for secure connectivity. Our cloud connectivity service is an easy to use, simple to manage and scalable solution for bandwidth-intensive connectivity to cloud service providers.”
PacketFabric customers can use its cloud connectivity service to connect to a cloud service from more than 150 on-net locations in North America, at speeds starting at 1Gbps.
PacketFabric will be at PTC 2018 in Honolulu, HI. To schedule a meeting with the PacketFabric team, please contact firstname.lastname@example.org.
For more information about PacketFabric, visit packetfabric.com.
PacketFabric redefines how companies procure, consume, and manage their network connectivity services. Leveraging an innovative, entirely automated SDN-based network architecture and the latest in optical and packet switching technology, PacketFabric enables dynamic, real-time connectivity services between major carrier-neutral colocation facilities at terabit-scale. PacketFabric facilitates coast-to-coast connectivity between more than 150 premier colocation facilities across 17 U.S. markets, and enables simple, cost-effective, and scalable network deployment via its advanced Application Program Interface (API) and web-based portal. For more information, visit www.packetfabric.com or connect with PacketFabric on Twitter, LinkedIn and Facebook.
NantWorks, LLC, founded by renowned physician scientist and inventor of the first human nanoparticle chemotherapeutic agent Abraxane®, Dr. Patrick Soon-Shiong, is the umbrella organization for the following entities: NantHealth, NantMobileHealth, NantOmics, NantBio, NantCell, NantPharma, NantCapital and NantCloud. Fact-based and solution-driven, each of NantWorks’ division entities operate at the nexus of innovation and infrastructure. The core mission of NantWorks is convergence and a systems approach to human biology: to develop and deliver a diverse range of technologies that accelerates innovation, broaden the scope of scientific discovery, enhance ground-breaking research, and improve healthcare treatment for those in need. NantWorks is building an integrated fact-based, genomically and proteomically-informed, personalized approach to the delivery of care and the development of next generation diagnostics and therapeutics for life threatening diseases such as Cancer, Infectious Diseases and Alzheimer’s. For more information please visit www.nantworks.com and follow Dr. Soon-Shiong on Twitter at @DrPatSoonShiong.